Seattle Genetics is one of the many companies that is determined to make the lives of all cancer patients better. It is making its way to the Cancer research field. This company has been in business for ten years and is steadily rising to take their position in the field. The Seattle Genetics was founded by Dr. Siegall in the year 1998 and Dr. Siegall has worked hard to ensure that the advancements and therapies to the patients to be gradually improved. Presently, the chairman of the Seattle Genetics’ board since the year 2002 as well as the CEO is Dr. Siegall.
Dr. Clay Siegall went to the George Washington University where he attained his Ph.D. in genetics. He then went ahead to start off as a Senior Research Investigator at the Bristol-Myers Squibb Pharmaceutical Research Institute. Within no time, Dr. Siegall had been promoted to become the Principal Scientist at the institution and finally became a staff fellow as well as a Biotechnology Fellow at the National Cancer Institute. While here, he started working on Seattle Genetics.
Dr. Siegall has maintained his attention on researching and implementing of high-tech advances that can help Cancer patients by ridding them of their pain. This is despite his impressive professional achievements. His aspirations and enthusiasm have led to the development of the first Antibody Drug Conjugate (ADC) that include ADCETRIS which was approved in 2011 and is now expanding and more available to patients in over 60 countries around the world.
Most news releases find Dr. Siegall to be compassionate and determined in his work and in the process helping those in dire need. The seattlepi.com considers Dr. Siegall’s accomplishments to be incredibly great as the use of the antibodies saves many lives. He works round the clock to establish new, more cutting-edge techniques of fighting with the illness. In addition, he is helping to come up with over $1.2 billion for his company.
Since he is the CEO of Seattle Genetics, his main role is to ensure that there are always new advancements being worked on at all times in order to sustain the Cancer patients. He directs his company in coming up with state-of-the-art technologies and techniques that can deal with Cancer. Dr. Siegall is, therefore, a blessing to the Cancer patients as he offers them hope each day.